AB 3621 – New Jersey
Status: In ProcessYear Introduced: 2024
Link: https://www.njleg.state.nj.us/bill-search/2024/A3621
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Key Issues:
PHARMACEUTICALS
Drug Pricing
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found